Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Ron Waksman

October 31, 2017

REGISTER for free or LOG IN to view this content

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Coronary

Presentation

TCT 2017

DES/BRS/DCB

Up Next

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stefan Verheye

October 31, 2017

More slides +

Presentation TCT 2017

TCT 21: Prevalence, Presentation and Treatment of Balloon Undilatable Chronic Total Occlusions: Multicenter US Experience

Presenter: Peter Tajti, MD

October 31, 2017

Presentation TCT 2017

TCT 22: Evaluation of the SoundBite Crossing System in a Coronary Chronic Total Occlusion (CTO) Acute Swine Model

Presenter: Raja Hatem

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.